121 related articles for article (PubMed ID: 218007)
1. Hypobetalipoproteinemic agents. 2. Compounds related to 4-(1-adamantyloxy)aniline.
Lednicer D; Heyd WE; Emmert DE; TenBrink RE; Schurr PE; Day CE
J Med Chem; 1979 Jan; 22(1):69-77. PubMed ID: 218007
[TBL] [Abstract][Full Text] [Related]
2. Biological activity of a hypobetalipoproteinemic agent.
Day CE; Schurr PE; Heyd WE; Lednicer D
Adv Exp Med Biol; 1976; 67(00):231-249. PubMed ID: 179296
[TBL] [Abstract][Full Text] [Related]
3. Hypobetalipoproteinemic agents. 3. Variation of the polycyclic portion of 4-(1-adamantyloxy)aniline.
Heyd WE; Bell LT; Heystek JR; Schurr PE; Day CE
J Med Chem; 1982 Sep; 25(9):1101-3. PubMed ID: 7131490
[No Abstract] [Full Text] [Related]
4. Hypo-beta-lipoproteinemic agents. 1. Bicyclo[2.2.2]octyloxyaniline and its derivatives.
Day CE; Schurr PE; Emmert DE; TenBrink RE; Lednicer D
J Med Chem; 1975 Nov; 18(11):1065-70. PubMed ID: 170403
[TBL] [Abstract][Full Text] [Related]
5. [Antiviral agents/4th communication: the aromatically substituted carbonic acid amide structure in potentically virustatic compounds (author's transl)].
Kreutzberger A; Schröders HH
Arzneimittelforschung; 1975 Jul; 25(7):994-7. PubMed ID: 1174415
[TBL] [Abstract][Full Text] [Related]
6. Response to the hypobetalipoproteinemic agent adamantyloxyphenyl piperidine in hyperlipemic rats.
Schurr PE; Day CE
Lipids; 1977 Jan; 12(1):22-8. PubMed ID: 189153
[TBL] [Abstract][Full Text] [Related]
7. Substituted 2-[(2-benzimidazolylsulfinyl)methyl]anilines as potential inhibitors of H+/K+ ATPase.
Adelstein GW; Yen CH; Haack RA; Yu S; Gullikson G; Price DV; Anglin C; Decktor DL; Tsai H; Keith RH
J Med Chem; 1988 Jun; 31(6):1215-20. PubMed ID: 2836591
[TBL] [Abstract][Full Text] [Related]
8. [Antimycotic agents. 7. Nuclear substituted N-(1-adamantyl)-N'-phenylthiourea derivatives].
Kreutzberger A; Tantawy A
Arch Pharm (Weinheim); 1978 Sep; 311(9):770-4. PubMed ID: 708208
[No Abstract] [Full Text] [Related]
9. [Synthesis and in vitro virucidal effect of recent 1-substituted adamantane derivatives].
Sztaricskai F; Pelyvás I; Dinya Z; Szilágyi L; Györgydeák Z; Hadházy G; Váczi L; Bognár R
Pharmazie; 1975 Sep; 30(9):571-81. PubMed ID: 1187737
[No Abstract] [Full Text] [Related]
10. Biologically active polycycloalkanes. 1. Antiviral adamantane derivatives.
Aigami K; Inamoto Y; Takaishi N; Hattori K; Takatsuki A
J Med Chem; 1975 Jul; 18(7):713-21. PubMed ID: 1171241
[TBL] [Abstract][Full Text] [Related]
11. 2-Adamantyl- and 2-adamantylidene-2-ethylamines.
Mariani E; Schenone P
Farmaco Sci; 1976 Apr; 31(4):272-6. PubMed ID: 939326
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of substituted 2-[(2-imidazolylsulfinyl)methyl]anilines as a new class of gastric H+/K(+)-ATPase inhibitors. II.
Yamakawa T; Matsukura H; Nomura Y; Yoshioka M; Masaki M; Harada H; Okabe S
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):675-82. PubMed ID: 1319287
[TBL] [Abstract][Full Text] [Related]
13. Phosphorus-nitrogen compounds. 21. Murine oncolytic and antifertility effect of adamantylaziridine compounds.
Cates LA; Cramer MB; Williams L
J Med Chem; 1978 Jan; 21(1):143-6. PubMed ID: 619145
[TBL] [Abstract][Full Text] [Related]
14. [Antiviral agents / 9th communication: virustatically active N-(1-adamantyl)-thiourea derivatives based on cyclic secondary amines (author's transl)].
Kreutzberger A; Schröders HH
Arzneimittelforschung; 1977; 27(5):969-72. PubMed ID: 577881
[TBL] [Abstract][Full Text] [Related]
15. [Antiviral agents. 6. Variation of substituents in the series of N'-substituted N-(adamantyl-(1))-thioureas].
Kreutzberger A; Schröders HH
Arch Pharm (Weinheim); 1975 Oct; 308(10):748-54. PubMed ID: 1200790
[No Abstract] [Full Text] [Related]
16. [Hypobetalipoproteinemic effect of trans-2,10-dichloro-6-ethoxycarbonyl-12-methyldibenzo[d,g] [1,3]dioxocin (EGYT-1932, Crismel)].
Maderspach A; Orbán E
Acta Pharm Hung; 1979 Jul; 49(4):182-6. PubMed ID: 224643
[No Abstract] [Full Text] [Related]
17. [Phosphoric esters of adamantanols, adamantanethiols, adamantyl alcohols and their alkyl derivatives, I: Synthese of the phosphoric esters of reaction with 2-chloro-1,3-dioxa-2-phosphorindane-2-oxide (author's transl)].
Böhringer H; Vogt H
Arch Pharm (Weinheim); 1977 Nov; 310(11):894-905. PubMed ID: 931578
[No Abstract] [Full Text] [Related]
18. General synthesis of potentially antiviral alpha-adamantyl carbonyl compounds.
Reetz MT; Maier WF; Schwellnus K; Chatziiosifidis I
Angew Chem Int Ed Engl; 1979 Jan; 18(1):72. PubMed ID: 105650
[No Abstract] [Full Text] [Related]
19. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
Chrysselis MC; Rekka EA; Kourounakis PN
J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
[TBL] [Abstract][Full Text] [Related]
20. Adamantane and protoadamantanealkanamines as potential anti-Parkinson agents.
Chakrabarti JK; Hotten TM; Sutton S; Tupper DE
J Med Chem; 1976 Jul; 19(7):967-9. PubMed ID: 940116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
